Navigation Links
WaferGen Bio-systems Awarded 1 Million Euro Grant by the Luxembourg Government to expand its European Operations
Date:9/18/2012

FREMONT, Calif., Sept. 18, 2012 /PRNewswire/ -- WaferGen Bio-systems, Inc. (OTCBB: WGBS) announced today the award of a 1 million Euro matching grant by the Luxembourg government to expand its European operations, headquartered in Luxembourg.  The first tranche of 350,000 Euros is expected to be received this quarter and will defray start-up and personnel costs.  WaferGen has started to recruit sales, support and technical personnel and plans to eventually establish research and diagnostic capabilities in Luxembourg.

"This grant will help us expand our European sales activities and enable us to provide regional support and service capabilities," said Ivan Trifunovich, President and CEO.  "We are grateful to receive this support from the government of Luxembourg and are looking forward to being a part of the country's growing biotechnology sector."

"Luxembourg has made significant progress in developing effective innovation networks with healthcare and biotechnology being one of the strategic areas of investment.  We are pleased to support WaferGen and the innovative technology it has developed," said Etienne Schneider, Minister of the Economy and Foreign Trade of the Grand-Duchy of Luxembourg.  "We believe its capabilities will complement the other life science initiatives in Luxembourg, including the collaboration with the Integrated Biobank of Luxembourg."

About WaferGen and the SmartChip Real-Time PCR System

WaferGen Bio-systems, Inc. is an innovative life science company that offers the SmartChip Real-Time PCR System—a next-generation genetic analysis platform for profiling and validating molecular biomarkers. It provides a range of high-throughput capabilities including microRNA and mRNA gene expression profiling as well as single nucleotide polymorphism (SNP) genotyping.   

For additional information, please see: http://www.wafergen.com <
'/>"/>

SOURCE WaferGen Bio-systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. WaferGen Bio-systems Announces Open Format qPCR Platform and Strategic Realignment
2. WaferGen to Present Corporate Overview at 5th Annual OneMedForum San Francisco 2012
3. WaferGen to Present Corporate Overview at Oppenheimer Healthcare Conference
4. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
5. Stanford faculty awarded $2.2 million for innovative energy research
6. CSL Biotherapies Awarded US Government Contract for Influenza Pandemic Preparedness and Response
7. Avery-Landsteiner Prize for Immunology Awarded to Alain Fischer of Paris, France, by German Society for Immunology
8. Trellis Bioscience Awarded SBIR Grant to Advance CMV Program
9. Astrix Technology Group Awarded Department of Homeland Security BioWatch Laboratory Staffing Contract
10. Ekahau - A Preferred Provider of Real-Time Location Solutions - Is Awarded an Agreement with the Premier Healthcare Alliance
11. Elusys Awarded Additional $50.2 Million Under An Exisiting U.S. Government Contract To Support Final Stages Of Development Of ETI-204, For Treatment Of Inhalational Anthrax
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... February 27, 2015 Cytokinetics, Incorporated (Nasdaq: ... February 28 with patients and health care advocates in ... Rare Disease Day®. Rare Disease Day is dedicated ... attention to the special challenges faced by patients with ... “Cytokinetics is proud to stand alongside patients and caregivers ...
(Date:2/26/2015)... , Feb. 26, 2015 On behalf of ... affiliated companies, Wilentz, Goldman & Spitzer, P.A. ... lawsuit against Genewiz Inc. in excess of $10 million. ... GenScript,s trade secrets, and that it improperly hired one ... order denying motions for judgment notwithstanding the verdict, a ...
(Date:2/26/2015)...   Regulus Therapeutics Inc . (NASDAQ: ... development of innovative medicines targeting microRNAs, today announced that ... Executive Officer of Regulus, will present a company overview ... Healthcare Conference on Wednesday, March 4, 2015 at 9:20 ... Boston Marriott Copley Place.  The presentation ...
(Date:2/26/2015)... On behalf of biotech client GenScript USA, ... & Spitzer, P.A. (Wilentz) secured a significant jury ... in excess of $10 million. The jury determined that ... that it improperly hired one or more of GenScript’s ... for judgment notwithstanding the verdict, a new trial, and ...
Breaking Biology Technology:Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3
... (NASDAQ: CPHD ) today announced that, together ... Jersey (UMDNJ), it has received a grant from the ... amplification methods for highly-sensitive detection of bloodstream bacteria using ... The $1.3 million grant is for the first year ...
... 19, 2012   Organovo Holdings, Inc. (OTCQB: ONVO) ... $15.2 million private placement. At the final closing, the ... sale of 6.9 million Units, at a price of ... approximately 43.7 million shares of common stock issued and ...
... of the world,s leading environmental scholars are sounding the alarm ... environmental institutions into a more coherent and robust planetary stewardship ... changes to the Earth,s subsystems. University of ... of a paper which appears in Science on ...
Cached Biology Technology:Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria 2Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria 3Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria 4Organovo Announces Close of $15.2 Million Private Placement to Advance 3D Bioprinting for Medical Applications 2Organovo Announces Close of $15.2 Million Private Placement to Advance 3D Bioprinting for Medical Applications 3Scholars call for global governance overhaul to ensure Earth's sustainability 2
(Date:2/5/2015)... -- New Market Research Reports Title Global ... 2020 has Been Added to GrandViewReseach.com Report Database ... reach USD 5.10 billion by 2020, according to a ... help identify the site of tissue damage in case ... in medical imaging applications. They have been extensively used ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... "Biometrics - A Global Market Overview" report to their ... technology is to ensure that an individual is who she/he ... may make use of a person,s unique physical characteristics, such ...
(Date:1/22/2015)...  BellBrook Labs, a leader in high throughput screening ... a TR-FRET (time resolved Forster resonance energy transfer) ... high throughput screening assay for glycosyltransferases and other ... sensitive detection of hundreds of human and microbial ...
Breaking Biology News(10 mins):IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2
... COLUMBIA, Mo. Millions of post-menopausal women use hormone ... associated with menopause. In a recent University of Missouri ... in HRT, a synthetic progestin, could be a major ... the researchers have compelling evidence that using an antibody ...
... What: Challenges and Promise of ... research in regenerative medicine using stem cells. The opening ... cell therapy. This will be followed by four plenary ... of neurological, cardiac, musculoskeletal, and metabolic diseases and disorders. ...
... Will April be the cruelest month? , ... are eerily reminiscent of 1993 and 1994, back-to-back years of serious ... of economic damage, damaging and destroying more than 50,000 homes and ... Parallels this year include abnormally high levels ...
Cached Biology News:MU researcher links hormone replacement therapy to breast cancer 2Challenges and promise of cell-based therapies 2Geologist decries floodplain development 2Geologist decries floodplain development 3
Anti-HumanLactoferrin...
Rabbit monoclonal [EP881Y] to EEF2K ( Abpromise for all tested applications). Antigen: Synthetic peptide corresponding to residues in the C-terminal of human EEF2K. Entrez GeneID: 29904 S...
ICAD Purified Anti-Mouse clone Polyclonal, Isotype Rabbit Ig, 200 µl Consult technical datasheet for details....
Rabbit polyclonal to M13 Bacteriophage Coat Proteins ( Abpromise for all tested applications)....
Biology Products: